Montelukast-Vertex, 5 mg 28 pcs

Blocker of cysteinyl leukotriene receptor CysLT1 (leukotrienes C4, D4 and E4 – mediators of chronic persistent inflammation, which supports bronchial hyperresponsiveness in bronchial asthma).

Prevent excessive formation of secretion in the bronchi, edema of the mucous membrane of the airways.

Limits the severity of bronchial asthma and the frequency of asthmatic attacks. It is highly effective when taken orally.

The bronchodilator effect develops within 1 day and lasts for a long time.

It is effective in patients with mild persistent asthma that is not sufficiently controlled by bronchodilators alone.

Indications

Bronchospasm, Allergic rhinitis, Bronchial asthma

Bronchial asthma (prevention and long-term treatment), complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose and sinuses and intolerance to ASA or others. NSAIDs (including history), bronchial asthma of physical stress, allergic rhinitis.

Active ingredient

Montelukast

Composition

Montelukast 5 mg.

How to take, the dosage

Overly, regardless of meals.

Adults and adolescents over 15 years of age – 10 mg once daily, before going to bed.

Children 6-14 years – 5 mg/day (one chewable tablet).

Special Instructions

Continue use is recommended even after significant improvement has been achieved.

Do not use to relieve acute asthmatic attacks, does not replace inhaled bronchodilators.

Contraindications

Hypersensitivity, children (under 6 years).

With caution. Pregnancy, lactation.

.

Side effects

Abdominal pain, headache, nausea, flu-like syndrome, cough, sinusitis, pharyngitis, increased activity of “liver” transaminases, allergic reactions.

.

Similarities

Singular, Montelar, Montelukast, Singlon, Montelukast, Almont, Glémont